174 related articles for article (PubMed ID: 29467457)
1. Adenylosuccinate lyase enhances aggressiveness of endometrial cancer by increasing killer cell lectin-like receptor C3 expression by fumarate.
Park H; Ohshima K; Nojima S; Tahara S; Kurashige M; Hori Y; Okuzaki D; Wada N; Ikeda JI; Morii E
Lab Invest; 2018 Apr; 98(4):449-461. PubMed ID: 29467457
[TBL] [Abstract][Full Text] [Related]
2. Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis.
Taha-Mehlitz S; Bianco G; Coto-Llerena M; Kancherla V; Bantug GR; Gallon J; Ercan C; Panebianco F; Eppenberger-Castori S; von Strauss M; Staubli S; Bolli M; Peterli R; Matter MS; Terracciano LM; von Flüe M; Ng CKY; Soysal SD; Kollmar O; Piscuoglio S
Theranostics; 2021; 11(9):4011-4029. PubMed ID: 33754045
[No Abstract] [Full Text] [Related]
3. Targeting the De Novo Purine Synthesis Pathway Through Adenylosuccinate Lyase Depletion Impairs Liver Cancer Growth by Perturbing Mitochondrial Function.
Jiang T; Sánchez-Rivera FJ; Soto-Feliciano YM; Yang Q; Song CQ; Bhuatkar A; Haynes CM; Hemann MT; Xue W
Hepatology; 2021 Jul; 74(1):233-247. PubMed ID: 33336367
[TBL] [Abstract][Full Text] [Related]
4. KLRC3, a Natural Killer receptor gene, is a key factor involved in glioblastoma tumourigenesis and aggressiveness.
Cheray M; Bessette B; Lacroix A; Mélin C; Jawhari S; Pinet S; Deluche E; Clavère P; Durand K; Sanchez-Prieto R; Jauberteau MO; Battu S; Lalloué F
J Cell Mol Med; 2017 Feb; 21(2):244-253. PubMed ID: 27641066
[TBL] [Abstract][Full Text] [Related]
5. Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer.
Zurlo G; Liu X; Takada M; Fan C; Simon JM; Ptacek TS; Rodriguez J; von Kriegsheim A; Liu J; Locasale JW; Robinson A; Zhang J; Holler JM; Kim B; Zikánová M; Bierau J; Xie L; Chen X; Li M; Perou CM; Zhang Q
Nat Commun; 2019 Nov; 10(1):5177. PubMed ID: 31729379
[TBL] [Abstract][Full Text] [Related]
6. Silencing of Dicer enhances dacarbazine resistance in melanoma cells by inhibiting ADSL expression.
Yeh YW; Hsu TW; Su YH; Wang CH; Liao PH; Chiu CF; Tseng PC; Chen TM; Lee WR; Tzeng YS
Aging (Albany NY); 2023 Nov; 15(22):12873-12889. PubMed ID: 37976135
[TBL] [Abstract][Full Text] [Related]
7. A Caenorhabditis elegans model of adenylosuccinate lyase deficiency reveals neuromuscular and reproductive phenotypes of distinct etiology.
Fenton AR; Janowitz HN; Franklin LP; Young RG; Moro CA; DeGennaro MV; McReynolds MR; Wang W; Hanna-Rose W
Mol Genet Metab; 2023 Nov; 140(3):107686. PubMed ID: 37607437
[TBL] [Abstract][Full Text] [Related]
8. Structural and biochemical characterization of human adenylosuccinate lyase (ADSL) and the R303C ADSL deficiency-associated mutation.
Ray SP; Deaton MK; Capodagli GC; Calkins LA; Sawle L; Ghosh K; Patterson D; Pegan SD
Biochemistry; 2012 Aug; 51(33):6701-13. PubMed ID: 22812634
[TBL] [Abstract][Full Text] [Related]
9. Pathway-specific effects of ADSL deficiency on neurodevelopment.
Dutto I; Gerhards J; Herrera A; Souckova O; Škopová V; Smak JA; Junza A; Yanes O; Boeckx C; Burkhalter MD; Zikánová M; Pons S; Philipp M; Lüders J; Stracker TH
Elife; 2022 Feb; 11():. PubMed ID: 35133277
[TBL] [Abstract][Full Text] [Related]
10. Mutation of a nuclear respiratory factor 2 binding site in the 5' untranslated region of the ADSL gene in three patients with adenylosuccinate lyase deficiency.
Marie S; Race V; Nassogne MC; Vincent MF; Van den Berghe G
Am J Hum Genet; 2002 Jul; 71(1):14-21. PubMed ID: 12016589
[TBL] [Abstract][Full Text] [Related]
11. Structural and kinetic analysis of Schistosoma mansoni Adenylosuccinate Lyase (SmADSL).
Romanello L; Serrão VHB; Torini JR; Bird LE; Nettleship JE; Rada H; Reddivari Y; Owens RJ; DeMarco R; Brandão-Neto J; Pereira HD
Mol Biochem Parasitol; 2017 Jun; 214():27-35. PubMed ID: 28347672
[TBL] [Abstract][Full Text] [Related]
12. Human adenylosuccinate lyase (ADSL), cloning and characterization of full-length cDNA and its isoform, gene structure and molecular basis for ADSL deficiency in six patients.
Kmoch S; Hartmannová H; Stibůrková B; Krijt J; Zikánová M; Sebesta I
Hum Mol Genet; 2000 Jun; 9(10):1501-13. PubMed ID: 10888601
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-21 guide and passenger strand regulation of adenylosuccinate lyase-mediated purine metabolism promotes transition to an EGFR-TKI-tolerant persister state.
Zhang WC; Skiados N; Aftab F; Moreno C; Silva L; Corbilla PJA; Asara JM; Hata AN; Slack FJ
Cancer Gene Ther; 2022 Dec; 29(12):1878-1894. PubMed ID: 35840668
[TBL] [Abstract][Full Text] [Related]
14. Purine Homeostasis Is Necessary for Developmental Timing, Germline Maintenance and Muscle Integrity in
Marsac R; Pinson B; Saint-Marc C; Olmedo M; Artal-Sanz M; Daignan-Fornier B; Gomes JE
Genetics; 2019 Apr; 211(4):1297-1313. PubMed ID: 30700528
[TBL] [Abstract][Full Text] [Related]
15. Carcinogenic effect of adenylosuccinate lyase (ADSL) in prostate cancer development and progression through the cell cycle pathway.
Liao J; Song Q; Li J; Du K; Chen Y; Zou C; Mo Z
Cancer Cell Int; 2021 Sep; 21(1):467. PubMed ID: 34488772
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of the AdeI mutant of Chinese hamster ovary cells: a cellular model of adenylosuccinate lyase deficiency.
Vliet LK; Wilkinson TG; Duval N; Vacano G; Graham C; Zikánová M; Skopova V; Baresova V; Hnízda A; Kmoch S; Patterson D
Mol Genet Metab; 2011 Jan; 102(1):61-8. PubMed ID: 20884265
[TBL] [Abstract][Full Text] [Related]
17. Mapping of the human adenylosuccinate lyase (ADSL) gene to chromosome 22q13.1-->q13.2.
Fon EA; Demczuk S; Delattre O; Thomas G; Rouleau GA
Cytogenet Cell Genet; 1993; 64(3-4):201-3. PubMed ID: 8404037
[TBL] [Abstract][Full Text] [Related]
18. Adenylosuccinate lyase (ADSL) and infantile autism: absence of previously reported point mutation.
Fon EA; Sarrazin J; Meunier C; Alarcia J; Shevell MI; Philippe A; Leboyer M; Rouleau GA
Am J Med Genet; 1995 Dec; 60(6):554-7. PubMed ID: 8825895
[TBL] [Abstract][Full Text] [Related]
19. Low gene expression levels of activating receptors of natural killer cells (NKG2E and CD94) in patients with fulminant type 1 diabetes.
Nakata S; Imagawa A; Miyata Y; Yoshikawa A; Kozawa J; Okita K; Funahashi T; Nakamura S; Matsubara K; Iwahashi H; Shimomura I
Immunol Lett; 2013; 156(1-2):149-55. PubMed ID: 24177169
[TBL] [Abstract][Full Text] [Related]
20. Fumaric acid production by Torulopsis glabrata: engineering the urea cycle and the purine nucleotide cycle.
Chen X; Wu J; Song W; Zhang L; Wang H; Liu L
Biotechnol Bioeng; 2015 Jan; 112(1):156-67. PubMed ID: 25060134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
